Search results for: Jason Sicklick

29 07, 2021

Q&A with SDH Panel of Experts Yields Promise for the SDH-deficient GIST Community

By |2021-07-29T11:58:30-04:00July 29th, 2021|News, Research, SDH-Deficient GIST|

The Life Raft Group celebrated GIST Awareness Day 2021 by holding an virtual, interactive Q&A session for SDH-deficient GIST patients with leading experts in the field.

29 06, 2021

Rare Diagnosis Fosters a Passion for Biomarker Testing & Self-Advocacy

By |2021-06-29T11:57:41-04:00June 29th, 2021|Member Stories, News, Newsletter|

GISTer Bill Borwegan shares his inspiring GIST journey illustrating the importance of biomarker/ mutational testing and self-advocacy as a rare disease patient.

3 06, 2021

It’s Time: The Life Raft Group Biomarker Testing Campaign – Educating & Informing Payers

By |2021-09-27T14:48:40-04:00June 3rd, 2021|Mutational Testing, News|

It's Time! Biomarker testing leads to an accurate diagnosis, avoiding the expense of unnecessary, expensive treatments. Biomarker testing leads to an accurate diagnosis, avoiding the expense of unnecessary, expensive treatments.

21 05, 2021

It’s Time: The Life Raft Group Biomarker Testing Campaign – The Physician Community Speaks

By |2021-09-27T14:51:43-04:00May 21st, 2021|Mutational Testing, News|

It's #TimeToGetTested. Understanding the role of mutations and biomarker testing is one of most important things patients must learn. It's time to bring together our physician community to raise their voices! In this post, we present out Biomarker Declaration for GIST pertaining to testing.

5 05, 2021

Annual Report 2020

By |2021-05-10T19:47:15-04:00May 5th, 2021|Annual Report, News|

Our theme for 2020 was Hope. 2020 presented a challenge to us all, but most especially to our patients and caregivers who are seeking to survive this rare cancer. In 2020, The Life Raft Group needed to provide a lifeline to our community, and to offer them hope in the form of increased support as we navigate the challenges of living in a COVID-19 world. #GISTHope

29 04, 2021

NIH Pediatric & Wildtype GIST Clinic 2021 Applications Are Open!

By |2021-04-23T10:48:08-04:00April 29th, 2021|News, Pediatric GIST, SDH-Deficient GIST|

The LRG will be collaborating with the NIH again in 2021 to hold the Virtual GIST Tumor Board in place of the NIH's Pediatric & Wildtype GIST Clinic normally held in the DC area. Applications to have cases reviewed are now open.

25 02, 2021

Heroes of Rare Disease: The 2021 Rare Impact Awards

By |2021-06-28T14:47:31-04:00February 25th, 2021|News, Research|

June 28th Awards Ceremony registration:   https://livingrare.org/rare-impact-awards/ Dr. Jason Sicklick, Blueprint Medicines Among Honorees Released 2/23/21 by NORD The National Organization for Rare Disorders (NORD®) announced this year’s Rare Impact Award honorees. These outstanding [...]

10 12, 2020

CTOS 2020 Virtual Session – Key Highlights

By |2020-12-10T21:48:53-05:00December 10th, 2020|Conferences, News|

CTOS 2020 was conducted virtually from November 18th through the 21st, given the nature of our current environment, much of the content of the conference centered on COVID-19 and its impact on cancer patients, but there were a number of sessions and presentations and posters devoted to GIST as well.

31 08, 2020

Virtual Life Fest 2020: SDH Panel Summary

By |2020-09-09T14:20:33-04:00August 31st, 2020|Events, News, SDH-Deficient GIST|

Over fifty participants attended a virtual meeting of SDH Experts in honor of GIST Awareness Day, July 13th, during Virtual Life Fest 2020. Questions were presented to the panel which included One of the first questions asked was “what specifically are your most challenging research hurdles and how can we, as patients and patient advocates from around the world help move research forward?”

Need a new search?

If you didn't find what you were looking for, try a new search!

Go to Top